Table 2.
Disease characteristics, baseline disease activity scores and pharmacological treatment of patients in the exercise and non-exercising disease control groups
| Exercise group (n = 13) | Control group (n = 7) | p-value | |
|---|---|---|---|
| Condition (%) | |||
| Ulcerative Colitis | 8 (61.5%) | 5 (71.4%) | 0.658a |
| Crohn’s Disease | 5 (38.5%) | 2 (28.6%) | |
| Age at diagnosis (years) | 25 (25, 31) | 26 (22, 31) | 0.642 |
| Previous surgery for condition | Yes: 1 (7.7%) | Yes: 0 | 0.452a |
| Baseline Disease activity score | |||
| Simple Colitis Index | 1.5 (1, 2.75) | 1 (0, 4) | 0.833 |
| Harvey Bradshaw Index | 1 (0, 1.5) | 1 (0, 1) | 1.00 |
| Disease treatment | |||
| Current steroid use | None | None | |
| Steroid use in the last year (%) | Yes: 5 (38.5%) No: 8 (61.5%) | Yes: 3 (42.9%) No: 4 (57.1%) | 0.848a |
| Current anti-TNF treatment | Yes: 2 (15.4%) No: 11 (84.6%) | Yes: 1 (14.3%) No: 6 (85.7%) | 0.948a |
| Currently on immunomodulation | Yes: 100% | Yes: 100% | |
| Azathioprine | N = 1 | N = 1 | |
| Mesalazine | N = 11 | N = 6 | |
| 6-mercaptopurine | N = 4 | N = 2 | |
| Proton pump inhibitors | N = 4 | N = 4 | |
Proportions, medians (interquartile ranges) are stated as appropriate. Mann-Whitney U and Chi-squared tests performed to compare groups. aIndicates Chi-squared test